Two canine Merkel cell tumours: Immunoexpression of c-KIT, E-cadherin, β-catenin and S100 protein

Veterinary Dermatology

Volumn 21, Issue 2, 2010, Pages 198-201

  Gil da Costa, Rui M ^a   Rema, Alexandra ^a   Pires, Maria A ^b   Gärtner, Fátima ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CADHERIN; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; TUMOR MARKER;

ANIMAL; ARTICLE; CASE REPORT; DOG; DOG DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MERKEL CELL TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BETA CATENIN; CADHERINS; CARCINOMA, MERKEL CELL; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; PROTO-ONCOGENE PROTEINS C-KIT; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 77951189196     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2009.00768.x     Document Type: Article

References (13)

1. Konno A, Nagata M, Nanko H. Immnohistochemical diagnosis of a Merkel cell tumor in a dog. Veterinary Pathology 1998, 35:538-40.
2. Gross TL, Ihrke PJ, Walder EJ. Skin Diseases of the Dog and Cat. Clinical and Histopathological Diagnosis 2005, 786-9. 2nd edn, Oxford, Blackwell Science Ltd, p
3. Aresu L, Tursi M, Iussich S. Use of S-100 and chromogranin A antibodies as immunohistochemical markers on detection of malignancy in aortic body tumors in dogs. The Journal of Veterinary Medical Science 2006, 68:1229-33.
4. Sako T, Uchida E, Okamoto M. Immunohistochemical evaluation of a malignant intestinal carcinoid in a dog. Veterinary Pathology 2003, 40:212-5.
5. Kerl H, Hofman-Wellenhof R. Cutaneous neuroendocrine carcinoma: Merkel cell carcinoma. Fitzpatrick's Dermatology in General Medicine 2003, 808-13. Freedberg IM, Eisen AZWolf K. In, eds, 6th edn, New York, MacGraw-Hill
6. Gil da Costa RM, Matos E, Rema A. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers. BMC Veterinary Research 2007, 3:19.
7. Swick BL, Ravdel L, Fitzpatrick JE. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the c-KIT proto-oncogene - implications for treatment with imatinib mesylate. Journal of Cutaneous Pathology 2007, 34:324-9.
8. Asioli S, Righi A, Volante M. P63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer 2007, 110:640-7.
9. Saraiva AL, Gärtner F, Pires MA. Expression of p63 in normal canine skin and primary cutaneous glandular carcinomas. Veterinary Journal 2008, 177:136-40.
10. Tanaka Y, Sano T, Qian ZR. Expression of adhesion molecules and cytokeratin 20 in Merkel cell carcinomas. Endocrine Pathology 2004, 15:117-29.
11. Gama A, Paredes J, Gärtner F. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Veterinary Journal 2008, 177:45-53.
12. Hsu SM, Faine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and the avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. American Journal of Clinical Pathology 1981, 75:734-8.
13. Kontochristopoulos GJ, Stavropoulos PG, Krasagakis K. Differentiation between Merkel cell carcinoma and malignant melanoma: an immunohistochemical study. Dermatology 2000, 201:123-6.